Correction: Symptom improvement in children with autism spectrum disorder following bumetanide administration is associated with decreased GABA/glutamate ratios (Translational Psychiatry, (2020), 10, 1, (9), 10.1038/s41398-020-0692-2)

Lingli Zhang, Chu Chung Huang, Yuan Dai, Qiang Luo, Yiting Ji, Kai Wang, Shining Deng, Juehua Yu, Mingyu Xu, Xiujuan Du, Yun Tang, Chun Shen, Jianfeng Feng, Barbara J. Sahakian, Ching Po Lin, Fei Li*

*Corresponding author for this work

Research output: Contribution to journalComment/debate

5 Scopus citations

Abstract

An important detail was omitted in the Method of the original Article, I.E, The CARS and other evaluations were conducted ‘blind' to condition (Bumetanide or no treatment) by experienced clinicians. This has now been updated in the HTML and PDF versions of this Article.

Original languageEnglish
Article number63
JournalTranslational Psychiatry
Volume10
Issue number1
DOIs
StatePublished - 1 Dec 2020

Fingerprint

Dive into the research topics of 'Correction: Symptom improvement in children with autism spectrum disorder following bumetanide administration is associated with decreased GABA/glutamate ratios (Translational Psychiatry, (2020), 10, 1, (9), 10.1038/s41398-020-0692-2)'. Together they form a unique fingerprint.

Cite this